STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Vivos Inc (RDGL) CEO Michael Korenko reports 100,000-share insider buy

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Vivos Inc. reported an insider share purchase by its CEO, President, and Director, Michael Korenko. On 12/02/2025, he bought 100,000 shares of Vivos Inc. common stock in an open-market transaction coded "P" at a price of $0.0722 per share. Following this transaction, he beneficially owns 10,735,090 shares of common stock in direct ownership.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Korenko Michael K

(Last) (First) (Middle)
C/O VIVOS INC
719 JADWIN AVENUE

(Street)
RICHLAND WA 99352

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
VIVOS INC [ RDGL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CEO AND PRESIDENT
3. Date of Earliest Transaction (Month/Day/Year)
12/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/02/2025 P 100,000 A $0.0722 10,735,090 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Michael Korenko 12/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Vivos Inc (RDGL) disclose?

Vivos Inc disclosed that its CEO, President, and Director, Michael Korenko, purchased 100,000 shares of the company’s common stock on 12/02/2025.

At what price were the Vivos Inc (RDGL) shares bought in this Form 4?

The reported purchase price was $0.0722 per share for the 100,000 shares of Vivos Inc common stock.

How many Vivos Inc (RDGL) shares does the insider own after the transaction?

After the reported transaction, Michael Korenko beneficially owns 10,735,090 shares of Vivos Inc common stock in direct ownership.

What is the role of the reporting person at Vivos Inc (RDGL)?

The reporting person, Michael Korenko, is a Director and serves as CEO and President of Vivos Inc.

Was this Vivos Inc (RDGL) insider transaction a purchase or a sale?

The Form 4 shows a transaction code "P", indicating a purchase of 100,000 shares of common stock.

Does the Vivos Inc (RDGL) Form 4 report any derivative securities?

The provided Table II section lists headings for derivative securities, but it does not show any specific derivative transactions or amounts.

Vivos

OTC:RDGL

RDGL Rankings

RDGL Latest News

RDGL Latest SEC Filings

RDGL Stock Data

42.50M
434.53M
4.41%
Medical Devices
Healthcare
Link
United States
Kennewick